<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The prevalence of anticardiolipin antibodies (aCL) and of <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> increases with age, and aCL may be associated with various diseases in the elderly </plain></SENT>
<SENT sid="1" pm="."><plain>So the significance of aCL in the elderly remains difficult to determine </plain></SENT>
<SENT sid="2" pm="."><plain>We sought to determine the significance of persistent <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) in the elderly </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We retrospectively analyzed the files of 327 patients [149 patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS); 64 patients age &gt;or= 65 yrs] with 2 positive aPL [<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC) and/or aCL] </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The frequency of APS was 40.8% (n = 134) in our 263 young patients (&lt; 65 yrs) and 23.4% (n = 15) in our 64 elderly patients (&gt;or= 65 yrs) </plain></SENT>
<SENT sid="5" pm="."><plain>The clinical characteristics of patients with persistent aPL were the same in those under and over 65 years </plain></SENT>
<SENT sid="6" pm="."><plain>LAC was positive in <z:hpo ids='HP_0000001'>all</z:hpo> but one elderly patient with APS, and occurred in this group more frequently than in the young patients (93.3% vs 44.6%; p &lt; 0.006) </plain></SENT>
<SENT sid="7" pm="."><plain>The presence of LAC allowed to discriminate APS patients in our elderly population (93.3% in APS vs 48.9% in non-APS patients; p &lt; 0.009) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Interpretation of a positive determination of APL is difficult in the elderly; persistent LAC may be the most valuable biological marker of APS in the elderly </plain></SENT>
</text></document>